Since there is no screening test for blood cancers, early detection is a challenge. But advances in blood cancer treatments are helping patients live longer, more fulfilling lives.

Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.

Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.

When the World Trade Centers evaporated on 9/11, clouds of toxic chemicals were left in their wake. Researchers wanted to know the impact of these clouds on the health of rescue workers.

Exposure to certain chemicals is thought to be a possible cause of a blood cancer called multiple myeloma. Researchers have honed in on this to see how occupation can affect risks.

One of the genes that helps to keep cancer from ever forming is the p53 gene. It works by blocking cancer cells from killing themselves. When p53 is messed up in some way, cancer cells go to town and wreak havoc.

Benzene is a chemical that's used in a number of industrial processes. People who are exposed to this chemical in the workplace may have increased cancer risks.

Multiple myeloma is a cancer similar to leukemia, where immune system cells in the blood begin to multiply out of control.

Things always go a little easier when you've got a friend by your side. As it turns out, that's true on a cellular level as well.

Doctors have to carefully watch their diabetes patients for other serious health problems like kidney disease and heart disease. Now, it seems doctors should keep an eye out for blood cancers as well.